Lawmakers investigate Vytorin ad campaign

01/16/2008 | Bloomberg

U.S. Reps. John Dingell and Bart Stupak asked the FDA and Vytorin developers Schering-Plough Corp. and Merck & Co. to submit documentation on the $200-million consumer ad campaign for the cholesterol drug, following the release of study results casting doubt on the drug's efficacy. The companies have said they are cooperating with the investigation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Vice President, Public Relations
iCrossing, Inc.
San Francisco, CA
Online Advertising Specialist
Tableau Softwarwe
Seattle, WA
Director, Digital Research (Burbank or New York)
Warner Bros. Entertainment Inc.
Burbank, CA
Data Entry and Integrity Coordinator
Interactive Advertising Bureau
New York, NY
Director of Business Development - Denver/New York
zvelo
Denver, CO